PHAT

Phathom Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth↑ 6/10
  • Momentum↑ 8/10
Phathom Pharmaceuticals sales and earnings growth
PHAT Growth
Good
  • Revenue Y/Y↑ 460.30%
  • EPS Y/Y↑ 34.43%
  • FCF Y/Y↑ 9.02%
Phathom Pharmaceuticals gross and profit margin trends
PHAT Profitability
Good
  • Gross margin ↑ 87.20%
  • EPS margin↓ -186.50%
  • ROIC↓ -37.00%
Phathom Pharmaceuticals net debt vs free cash flow
PHAT Risk
Great
  • Debt / Equity↓ -1.3
  • Debt / FCF↓ 1.9
  • Interest coverage↓ -2.9

Phathom Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗